Prevalence of primary and secondary antimicrobial resistance of Helicobacter pylori in Korea from 2003 through 2012.
about
Antibiotic treatment for Helicobacter pylori: Is the end coming?Role of Helicobacter pylori infection in gastric carcinogenesis: Current knowledge and future directionsSecond and third line treatment options for Helicobacter pylori eradicationA review of Helicobacter pylori diagnosis, treatment, and methods to detect eradication.Functional and molecular surveillance of Helicobacter pylori antibiotic resistance in Kuala LumpurPrimary Antibiotic Resistance of Helicobacter pylori in China.Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance.Efficacy and Safety of the Triple Therapy Containing Ilaprazole, Levofloxacin, and Amoxicillin as First-Line Treatment in Helicobacter pylori Infections.Helicobacter pylori from Peptic Ulcer Patients in Uganda Is Highly Resistant to Clarithromycin and Fluoroquinolones: Results of the GenoType HelicoDR Test Directly Applied on StoolHelicobacter pylori eradication with moxifloxacin-containing therapy following failed first-line therapies in South KoreaConcomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.Efficacy of moxifloxacin-based sequential therapy for first-line eradication of Helicobacter pylori infection in gastrointestinal disease.The Primary Resistance of Helicobacter pylori in Taiwan after the National Policy to Restrict Antibiotic Consumption and Its Relation to Virulence Factors-A Nationwide Study.Appropriate first-line regimens to combat Helicobacter pylori antibiotic resistance: an Asian perspective.Efficacy of 7-Day and 14-Day Bismuth-Containing Quadruple Therapy and 7-Day and 14-Day Moxifloxacin-Based Triple Therapy as Second-Line Eradication for Helicobacter pylori Infection.Fourteen- vs seven-day bismuth-based quadruple therapy for second-line Helicobacter pylori eradicationEfficacy of moxifloxacin-based sequential and hybrid therapy for first-line Helicobacter pylori eradicationComparison of sequential therapy and amoxicillin/tetracycline containing bismuth quadruple therapy for the first-line eradication of Helicobacter pylori: a prospective, multi-center, randomized clinical trial.Early Attempts to Eradicate Helicobacter pylori after Endoscopic Resection of Gastric Neoplasm Significantly Improve Eradication Success Rates.Surveillance of Helicobacter pylori Antibiotic Susceptibility in Indonesia: Different Resistance Types among Regions and with Novel Genetic Mutations.Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradicationTrends in Helicobacter pylori eradication rates by first-line triple therapy and related factors in eradication therapy.High Efficacy of Finafloxacin on Helicobacter pylori Isolates at pH 5.0 Compared with That of Other Fluoroquinolones.Moxifloxacin-containing triple therapy after non-bismuth quadruple therapy failure for Helicobacter pylori infectionSystematic review with meta-analysis: the efficacy of vonoprazan-based triple therapy on Helicobacter pylori eradication.High Dose Ilaprazole/Amoxicillin as First-Line Regimen for Helicobacter pylori Infection in Korea.Sequential Therapy versus Triple Therapy for the First Line Treatment of Helicobacter pylori in Korea: A Nationwide Randomized Trial.Signal Detection of Adverse Drug Reaction of Amoxicillin Using the Korea Adverse Event Reporting System Database.Long-term pretreatment with proton pump inhibitor and Helicobacter pylori eradication ratesCurrent progress toward eradicating Helicobacter pylori in East Asian countries: differences in the 2013 revised guidelines between China, Japan, and South Korea.Current recommendations for Helicobacter pylori therapies in a world of evolving resistance.Efficacy of Levofloxacin-Based Third-Line Therapy for the Eradication of Helicobacter pylori in Peptic Ulcer Disease.Treatment of Helicobacter pylori infection 2013.Is levofloxacin-based triple therapy an alternative for first-line eradication of Helicobacter pylori? A systematic review and meta-analysis.Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition.Culture-guided treatment approach for Helicobacter pylori infection: review of the literature.Overview of the phytomedicine approaches against Helicobacter pylori.Antimicrobial susceptibility testing for Helicobacter pylori in times of increasing antibiotic resistance.Treatment of Helicobacter pylori infection 2014.Eradication Rates of Helicobacter pylori in Korea Over the Past 10 years and Correlation of the Amount of Antibiotics Use: Nationwide Survey.
P2860
Q26777623-55FB1F7D-3E5B-4F25-8A89-153871A12621Q26778023-7751B9A5-F461-4D56-B0C7-D8A395148B27Q26829666-173241B9-AC1E-4000-9399-9C693D07319AQ27687842-868740B6-C602-480E-A7F3-071175EE341AQ28540466-3913BD38-DA53-47C6-BD07-D598665D2160Q30235219-3AB2AEF6-2139-434D-910D-A0DBB589B5C6Q33639114-137B0C41-79CD-4B8F-9B29-4282B0769D64Q33678973-FC2A7B72-8879-4428-B389-D994507EF951Q33710414-5472F111-46A5-4700-A820-23B0F117FB62Q33735315-0DE169EE-54F6-4A25-AF67-DF45B256FCDAQ34827671-9521803E-04D7-4E2B-8E2C-B16A71FD9B17Q35534113-1DA67E30-0882-4062-84B7-BADBCFB8C4EAQ35571249-CB2784ED-D2D5-4BD1-8BDB-DA75D6365333Q35598058-2272BF14-F3E9-481F-883D-43BB66FCA4FAQ35771863-F2176CCE-FF13-4C06-B55D-55685138AC35Q35843088-F4490034-9D64-438C-B1F6-1B30ADB9CFBBQ36067627-BA4923BC-12AA-49CF-AA26-4E054911ECF9Q36086358-B87328C8-6044-4227-AD20-58711F275545Q36121419-D3371319-BC50-4552-800C-5E50AF0D342CQ36209645-8B5B9510-A886-4F1F-95FB-0A91EB13DB3AQ36256381-0154D549-8ADD-44D0-AE37-08E173A2811AQ36272074-EA0EC83C-8EFD-40F8-BF2A-DBB77C2B8211Q36290512-E2A75569-65B3-4A2E-9A73-C6646CA2A332Q36360839-6545C257-8D33-4126-96B0-88D662ED6DA7Q36369941-32AE5B80-F26C-4943-9B68-6355558236D3Q37060060-DD6110E9-60B9-447E-86BC-262F7EE2EB43Q37066366-9F079DB3-0268-4E29-81CE-C7F948711903Q37153166-17B368B6-01BD-46EE-ADBC-32C5056E29D7Q37578697-5A9E7C6E-5B03-4D1C-A034-E008ABEB2B0CQ37587260-4A6B8E25-ED65-40D6-B40F-3A0F90C19E02Q37591509-68730F05-39BE-4C14-94D8-975AEDA804BCQ37696038-989A4646-9D53-410A-8E12-3C0ADA587032Q38134877-2229D978-778D-4481-A57E-357D1CFF7681Q38194611-5DEC1961-E604-41C5-A793-7FCA11520F54Q38206548-218E2076-ACC8-49D6-9529-3597D527E15FQ38212210-0C1370B1-A545-4236-9801-A9F9352551F8Q38219017-675B9F18-B0A3-4D77-9814-517D26F3CE7AQ38238746-21688EC2-C44C-44F6-8CD1-12C88B44A235Q38244257-C5633CE5-C39C-4A62-82B1-5CD590FD3879Q38608130-2D48F900-CEA2-4C98-B81E-553C69603F93
P2860
Prevalence of primary and secondary antimicrobial resistance of Helicobacter pylori in Korea from 2003 through 2012.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Prevalence of primary and seco ...... Korea from 2003 through 2012.
@en
Prevalence of primary and seco ...... Korea from 2003 through 2012.
@nl
type
label
Prevalence of primary and seco ...... Korea from 2003 through 2012.
@en
Prevalence of primary and seco ...... Korea from 2003 through 2012.
@nl
prefLabel
Prevalence of primary and seco ...... Korea from 2003 through 2012.
@en
Prevalence of primary and seco ...... Korea from 2003 through 2012.
@nl
P2093
P2860
P356
P1433
P1476
Prevalence of primary and seco ...... Korea from 2003 through 2012.
@en
P2093
Cheol Min Shin
Dong Ho Lee
Hyun Chae Jung
Hyun Chang
Jae Yeon Kim
Jung Mogg Kim
Jung Won Lee
Ryoung Hee Nam
Young Soo Park
P2860
P304
P356
10.1111/HEL.12031
P50
P577
2012-12-13T00:00:00Z